Last reviewed · How we verify
NCT06120153
Point of Care Polymerase Chain Reaction (PCR) Diagnostics of Respiratory Tract Infections in General Practice
NA trial testing POC PCR-test device in Respiratory Tract Infections in 5,700 participants. Participants enrolled and being followed up; not accepting new ones.
22 March 2026
Quick facts
| Lead sponsor | University of Southern Denmark |
|---|---|
| Phase | NA |
| Status | Active, enrolled |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | crossover |
| Masking | none |
| Primary purpose | health services research |
| Enrollment | 5,700 |
| Start date | 30 October 2023 |
| Primary completion | 22 March 2026 |
| Estimated completion | 22 March 2026 |
| Sites | 1 location across Denmark |
Drugs / interventions tested
- POC PCR-test device
Conditions studied
- Respiratory Tract Infections — all drugs for Respiratory Tract Infections →
Sponsor
University of Southern Denmark
Who can join
0 and older, any sex, with Respiratory Tract Infections. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The present study will assess the effect and cost-effectiveness of the availability of point-of-care (POC) PCR testing, in respiratory tract infections (RTIs) in general practice, compared with usual care.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Evaluating the Effect of a Molecular Point-of-Care Test on Acute Respiratory Infections in General Practice: Protocol for a Cluster Randomized Trial.
Balasubramaniam K, Simonsen LM, Kongstad LP, Thilsing T, et al · · 2025 · PMID 40921063 · DOI 10.2196/72842
Verify or expand the search:
- PubMed search for NCT06120153
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Respiratory Tract Infections
Currently open trials in the same condition.
- NCT07207291 — Phase I Study of Single/Multiple Ascending Doses of JKN2501 for Injection in Chinese Healthy Volunteers · Phase 1 · recruiting
- NCT06715306 — Intravenous Versus Oral Treatment of the Main Acute Infections · NA · recruiting
- NCT06472219 — PREDICATE Trial For Respiratory Tract Infections · Phase 3 · recruiting
- NCT05914324 — Outpatient Pediatric Pulse Oximeters in Africa · NA · recruiting
- NCT06579170 — Burden of Recreational Water Illness Due to Exposure to Cyanobacteria and Their Toxins in Freshwater Beaches in Canada · active not recruiting
Other University of Southern Denmark trials
Trials by the same sponsor.
- NCT07531290 — PeerScreen Trial - Reducing Screen Media Use in Peer-groups of Young People · NA · not yet recruiting
- NCT07384273 — Evaluating the Effectiveness of an Internet-based Therapy (iCARE) to Treat Symptoms of Postpartum Depression · NA · recruiting
- NCT07426679 — Should Anaesthesiologists Be Taught to Perform Ultrasound-- Assisted Neuraxial Access in Spinal Anaesthesia? · NA · recruiting
- NCT07104292 — Pelvic Floor Muscle Training During Pregnancy · NA · recruiting
- NCT07194759 — Health Literacy Levels of Patients Living With Type 2 Diabetes and Multi-disease and Their Families Using HLQTM · enrolling by invitation
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06120153 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by University of Southern Denmark
- Last refreshed: 31 July 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06120153.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing